Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis

The immune escape in melanoma: role of the impaired dendritic cell function

(2014) Marco Tucci et al.   Expert Review of Clinical Immunology

Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies

(2014) G. K. Philips et al.   INTERNATIONAL IMMUNOLOGY

Combination Therapy with Thymosin Alpha1 and Dexamethasone Helps Mice Survive Sepsis

(2013) Xiao-song Xiang et al.   INFLAMMATION

Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond

(2012) Riccardo Danielli et al.   Annals of the New York Academy of Sciences

Jack of all trades: thymosin α1 and its pleiotropy

(2012) Luigina Romani et al.   Annals of the New York Academy of Sciences

Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

(2012) A. Ciancio et al.   JOURNAL OF VIRAL HEPATITIS

Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice

(2011) Jian Wan   Frontiers in Bioscience-Landmark

Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study

(2011) G. Carraro et al.   VACCINE

Thymosin alpha 1: past clinical experience and future promise

(2010) Cynthia Tuthill et al.   Annals of the New York Academy of Sciences

Thymosin α1: the regulator of regulators?

(2010) Bonifazi Pierluigi et al.   Annals of the New York Academy of Sciences

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

(2010) Michele Maio et al.   JOURNAL OF CLINICAL ONCOLOGY

From lab to bedside: emerging clinical applications of thymosin α1

(2009) Allan L Goldstein et al.   EXPERT OPINION ON BIOLOGICAL THERAPY